Non-Therapeutic Protocol
PTSD2: Stress, Adjustment and Growth in Children with Cancer and Their Parents
Type of Protocol/Clinical Study
Supportive Studies: Long Term Effects
Description
Childhood cancer is a significant event for the patient and family and can have both positive and negative effects. Most studies to date have focused on the negative effects (such as stress, worries, sadness) and not on the possible positive effects. This study will look at both positive and negative outcomes that occur in children with cancer and their parents.
The aims of this proposal will be addressed with a two-group (cancer and healthy control), cross-sectional, longitudinal design, using patient self-report, parent-report, and structured diagnostic interviews as the primary sources of data.
Objectives
- To examine the outcomes of stress, adjustment, and growth in children through a comparison of children with cancer/cancer survivors and a population of children without a history of serious illness.
- To look at factors that predict stress, adjustment, and growth responses in children.
- To examine the outcomes of stress, adjustment, and growth in parents of children with cancer/cancer survivors in comparison to parents of healthy children.
- To look at factors that predict stress, adjustment, and growth in parents.
- To examine the usefulness of self-report measures as screening tools for outcomes of stress, adjustment, and growth.
- To examine the properties of a new questionnaire regarding child personality.
- To examine new social age-related outcomes over time.
Eligibility
Primary Group
- Research participant is 8-17 years inclusive
- Research participant has a primary diagnosis of malignancy
- Research participant is at least one month from diagnosis with no upper limit in terms of time elapsed since diagnosis
- Research participant is able to speak and read English
- Research participant does not have any significant cognitive or sensory deficits that would preclude participation
- Parent/LAR and research participant is willing to participate and provide consent/assent
Young Child Group
- Research participant is 3–6 years of age, inclusive
- Primary diagnosis of malignancy
- At least one month from diagnosis
- One parent/LAR willing to participate and provide consent
Young Adult Group
- Research participant is 18-25 years of age inclusive
- Primary diagnosis of malignancy
- At least one month from diagnosis with no upper limit in terms of time elapsed from diagnosis
- Able to read and speak English
- No cognitive or sensory deficits that would preclude participation
- Willing to participate and provide consent
Exclusion criteria for enrollment
- Cognitive impairment/defect
Principal Investigator
Sean Phipps, PhD
The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.